Therapeutic potential of caffeic acid phenethyl ester and its anti-inflammatory and immunomodulatory effects

被引:126
作者
Armutcu, Ferah [1 ]
Akyol, Sumeyya [2 ]
Ustunsoy, Seyfettin [3 ]
Turan, Fatime Filiz [3 ]
机构
[1] Istanbul Univ, Cerrahpasa Med Fac, Dept Biochem, TR-34098 Istanbul, Turkey
[2] Turgut Ozal Univ, Fac Med, Dept Med Biol, TR-06010 Ankara, Turkey
[3] Fatih Univ, Fac Med, Dept Biochem, TR-34500 Istanbul, Turkey
关键词
caffeic acid phenethyl ester; anti-inflammatory activity; immunomodulatory effect; NF-KAPPA-B; NUCLEAR-FACTOR; TRANSCRIPTION FACTOR; NITRIC-OXIDE; EPITHELIAL-CELLS; MURINE MODEL; IN-VITRO; INFLAMMATION; ACTIVATION; INHIBITION;
D O I
10.3892/etm.2015.2346
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Caffeic acid phenethyl ester (CAPE), a naturally occurring compound isolated from propolis extract, has been reported to have a number of biological and pharmacological properties, exerting antioxidant, anti-inflammatory, anticarcinogenic, antibacterial and immunomodulatory effects. Recent in vivo and in vitro study findings have provided novel insights into the molecular mechanisms involved in the anti-inflammatory and immunomodulatory activities of this natural compound. CAPE has been reported to have anti-inflammatory properties involving the inhibition of certain enzyme activities, such as xanthine oxidase, cyclooxygenase and nuclear factor-kappa B (NF-kappa B) activation. Since inflammation. and immune mechanisms play a crucial role in the onset of several inflammatory diseases, the inhibition of NF-kappa B represents a rationale for the development of novel and safe anti-inflammatory agents. The primary goal of the present review is to highlight the anti-inflammatory and immunomodulatory activities of CAPE, and critically evaluate its potential therapeutic effects.
引用
收藏
页码:1582 / 1588
页数:7
相关论文
共 59 条
  • [1] Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45
    Aihara, M
    Tsuchimoto, D
    Takizawa, H
    Azuma, A
    Wakebe, H
    Ohmoto, Y
    Imagawa, K
    Kikuchi, M
    Mukaida, N
    Matsushima, K
    [J]. INFECTION AND IMMUNITY, 1997, 65 (08) : 3218 - 3224
  • [2] In Vivo and In Vitro Antneoplastic Actions of Caffeic Acid Phenethyl Ester (CAPE): Therapeutic Perspectives
    Akyol, Sumeyya
    Ozturk, Gulfer
    Ginis, Zeynep
    Armutcu, Ferah
    Yigitoglu, M. Ramazan
    Akyol, Omer
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2013, 65 (04): : 515 - 526
  • [3] Caffeic acid phenethyl ester improves oxidative erythrocyte damage in a rat model of thermal injury
    Armutcu, F
    Gürel, A
    Hosnuter, M
    Pabuçcu, O
    Altinyazar, C
    [J]. JOURNAL OF BURN CARE & REHABILITATION, 2004, 25 (02): : 171 - 178
  • [4] Inflammation and cancer: back to Virchow?
    Balkwill, F
    Mantovani, A
    [J]. LANCET, 2001, 357 (9255) : 539 - 545
  • [5] The two NF-κB activation pathways and their role in innate and adaptive immunity
    Bonizzi, G
    Karin, M
    [J]. TRENDS IN IMMUNOLOGY, 2004, 25 (06) : 280 - 288
  • [6] NUCLEAR FACTOR-KAPPA β REGULATES NOTCH SIGNALING IN PRODUCTION OF PROINFLAMMATORY CYTOKINES AND NITRIC OXIDE IN MURINE BV-2 MICROGLIAL CELLS
    Cao, Q.
    Kaur, C.
    Wu, C. -Y.
    Lu, J.
    Ling, E. -A.
    [J]. NEUROSCIENCE, 2011, 192 : 140 - 154
  • [7] Chemoprotective effect of caffeic acid phenethyl ester on promotion in a medium-term rat hepatocarcinogenesis assay
    Carrasco-Legleu, CE
    Márquez-Rosado, L
    Fattel-Fazenda, S
    Arce-Popoca, E
    Pérez-Carreón, JI
    Villa-Treviño, S
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (04) : 488 - 492
  • [8] Chen F, 1999, CLIN CHEM, V45, P7
  • [9] The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells
    Chen, YJ
    Shiao, MS
    Wang, SY
    [J]. ANTI-CANCER DRUGS, 2001, 12 (02) : 143 - 149
  • [10] Administration of antisense phosphorothioate oligonucleotide to the p65 subunit of NF-κB inhibits established asthmatic reaction in mice
    Choi, IW
    Kim, DK
    Ko, HM
    Lee, HK
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2004, 4 (14) : 1817 - 1828